Clinical Trials
Now Enrolling
BAROSTIM NEO® - BEAT-HF
Baroreflex Activation Therapy for Heart Failure
Principal Investigator: Dr. Forman
A trial for heart failure patients with reduced ejection fraction. Subjects are randomized to receive
either Barostim activation therapy with the Barostim neo system/medical management or to receive medical management alone.
An Investigation of the Role of Germ-line Mutations in Cancer Predisposition, Tumor Biology and Response to Treatment
Principal Investigator: Dr. Kwon
A study to find and confirm genetic or inherited differences between cancer patients, to help us learn how to best treat cancer patients with radiation.
Upcoming Studies
1. A Phase 3 Multicenter, Randomized, Open-label, Clinical Trial of Telavancin Versus Standard Intravenous Therapy in the Treatment of Subjects with Staphylococcus aureus Bacteremia Including Infective Endocarditis.
Principal Investigator - Dr. Schneider
A trial to compare telavancin to standard IV therapy in the treatment of S. aureus bacteremia, and S. aureus right-sided infective endocarditis.
2. Genetic Variation, Stress, & Functional Outcomes after Stroke R Rehabilitation
(STRONG)
Principal Investigator - Dr. N. Patel
A trial for those affected by a stroke. STRONG will examine how stress and genetics can affect rehab after stroke.
3. Atrial Cardiopathy & Antithrombotic Drugs
In Prevention After Cryptogenic Stroke (ARCADIA)
Principal Investigator - Dr. N. Patel
A trial for those affected by a stroke. STRONG will examine how stress and genetics can affect rehab after stroke.
Approved Humanitarian Use Devices (HUD)
1. Codman Enterprise Vascular Reconstruction Device & Delivery System
Principal Investigator -Dr. Farid
2. Graftmaster RX Coronary Stent Graft System
Principal Investigator-Dr. Fischer
3. Neuroform Microdelivery Stent
System
Principal Investigator-Dr. Farid
4. Wingspan Stent System with Gateway PTA Balloon Catheter
Principal Investigator-Dr. Farid
For further information, contact Margaret Villa RN, 562-799-3104